NewLimit Raises $40 Million To Reverse Aging
By Annie Baker ● Jun 4, 2023
NewLimit - a San Francisco-based company that aims to reverse aging by reprogramming cells - announced recently that it raised $40 million in funding in a Series A round of funding from Dimension, Founders Fund, and Kleiner Perkins with participation from Eric Schmidt, Elad Gil, Garry Tan, and Fred Ehrsam.